...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Promissory Note
6
Mar 09, 2021 04:20PM
4
Mar 09, 2021 08:47PM
3
Mar 10, 2021 07:12AM
1
Mar 10, 2021 07:19AM

That's all of the info. there is on SEDAR.

3
Mar 10, 2021 04:16PM
Share
New Message
Please login to post a reply